380 related articles for article (PubMed ID: 33566579)
1. Influence of Lipid Membranes on α-Synuclein Aggregation.
Kurochka AS; Yushchenko DA; Bouř P; Shvadchak VV
ACS Chem Neurosci; 2021 Mar; 12(5):825-830. PubMed ID: 33566579
[TBL] [Abstract][Full Text] [Related]
2. The effect of fluorescent labeling on α-synuclein fibril morphology.
Mučibabić M; Apetri MM; Canters GW; Aartsma TJ
Biochim Biophys Acta; 2016 Oct; 1864(10):1419-27. PubMed ID: 27475048
[TBL] [Abstract][Full Text] [Related]
3. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.
Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854
[TBL] [Abstract][Full Text] [Related]
4. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
Galvagnion C
J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein aggregation at low concentrations.
Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
[TBL] [Abstract][Full Text] [Related]
6. Membrane lipid co-aggregation with α-synuclein fibrils.
Hellstrand E; Nowacka A; Topgaard D; Linse S; Sparr E
PLoS One; 2013; 8(10):e77235. PubMed ID: 24146972
[TBL] [Abstract][Full Text] [Related]
7. Direct Visualization of Model Membrane Remodeling by α-Synuclein Fibrillization.
Chaudhary H; Subramaniam V; Claessens MMAE
Chemphyschem; 2017 Jun; 18(12):1620-1626. PubMed ID: 28370874
[TBL] [Abstract][Full Text] [Related]
8. Rationally Designed Protein-Based Inhibitor of α-Synuclein Fibrillization in Cells.
Priss A; Afitska K; Galkin M; Yushchenko DA; Shvadchak VV
J Med Chem; 2021 May; 64(10):6827-6837. PubMed ID: 33970620
[TBL] [Abstract][Full Text] [Related]
9. The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of
Sternke-Hoffmann R; Peduzzo A; Bolakhrif N; Haas R; Buell AK
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183378
[TBL] [Abstract][Full Text] [Related]
10. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
[TBL] [Abstract][Full Text] [Related]
11. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein.
Galvagnion C; Brown JW; Ouberai MM; Flagmeier P; Vendruscolo M; Buell AK; Sparr E; Dobson CM
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7065-70. PubMed ID: 27298346
[TBL] [Abstract][Full Text] [Related]
12. N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates.
Bell R; Thrush RJ; Castellana-Cruz M; Oeller M; Staats R; Nene A; Flagmeier P; Xu CK; Satapathy S; Galvagnion C; Wilson MR; Dobson CM; Kumita JR; Vendruscolo M
Biochemistry; 2022 Sep; 61(17):1743-1756. PubMed ID: 35944093
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein fibril and synaptic vesicle interactions lead to vesicle destruction and increased lipid-associated fibril uptake into iPSC-derived neurons.
Stephens AD; Villegas AF; Chung CW; Vanderpoorten O; Pinotsi D; Mela I; Ward E; McCoy TM; Cubitt R; Routh AF; Kaminski CF; Kaminski Schierle GS
Commun Biol; 2023 May; 6(1):526. PubMed ID: 37188797
[TBL] [Abstract][Full Text] [Related]
14. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
[TBL] [Abstract][Full Text] [Related]
15. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration.
Ziaunys M; Sakalauskas A; Mikalauskaite K; Smirnovas V
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830264
[TBL] [Abstract][Full Text] [Related]
17. Single fibril growth kinetics of α-synuclein.
Wördehoff MM; Bannach O; Shaykhalishahi H; Kulawik A; Schiefer S; Willbold D; Hoyer W; Birkmann E
J Mol Biol; 2015 Mar; 427(6 Pt B):1428-1435. PubMed ID: 25659910
[TBL] [Abstract][Full Text] [Related]
18. Fibril breaking accelerates α-synuclein fibrillization.
Shvadchak VV; Claessens MM; Subramaniam V
J Phys Chem B; 2015 Feb; 119(5):1912-8. PubMed ID: 25582977
[TBL] [Abstract][Full Text] [Related]
19. Eye lens crystallin proteins inhibit the autocatalytic amyloid amplification nature of mature α-synuclein fibrils.
Gaspar R; Garting T; Stradner A
PLoS One; 2020; 15(6):e0235198. PubMed ID: 32598365
[TBL] [Abstract][Full Text] [Related]
20. Structural and mechanistic insights into amyloid-β and α-synuclein fibril formation and polyphenol inhibitor efficacy in phospholipid bilayers.
Sanders HM; Jovcevski B; Marty MT; Pukala TL
FEBS J; 2022 Jan; 289(1):215-230. PubMed ID: 34268903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
